HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3',11-dibutyrylankinomycin (AN 1006)

structure given in first source

Also Known As:

AN 1006; AN-1006; AN1006

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - 3',11-dibutyrylankinomycin: 1

Related Diseases

1.	Neoplasms (Cancer) 01/01/1993 - "AN1006 was effective against multidrug-resistant tumors in vitro and in vivo. " 01/01/1993 - "The antitumor activity of AN1006 was dependent on the administration schedule, and on the most effective schedule, AN1006 showed activity comparable with that of Adriamycin (ADM) against murine solid tumors and leukemias. "
2.	Leukemia 01/01/1993 - "AN1006 showed a cytotoxic spectrum different from that of ADM, exhibiting cytotoxicity stronger than that of ADM against colon carcinoma, stomach carcinoma, and some leukemia cell lines. " 01/01/1993 - "The antitumor activity of AN1006 was dependent on the administration schedule, and on the most effective schedule, AN1006 showed activity comparable with that of Adriamycin (ADM) against murine solid tumors and leukemias. "
3.	Carcinoma (Carcinomatosis) 01/01/1993 - "According to these in vitro effects, AN1006 showed antitumor activity superior to and equal to that of ADM against human colon xenografts and stomach carcinoma xenografts in athymic nude mice, respectively. " 01/01/1993 - "AN1006 showed a cytotoxic spectrum different from that of ADM, exhibiting cytotoxicity stronger than that of ADM against colon carcinoma, stomach carcinoma, and some leukemia cell lines. "

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)